Could a diabetes drug fix period problems in teens with type 1?

NCT ID NCT07319286

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study looks at whether dulaglutide, a drug used for type 2 diabetes, can help regulate menstrual cycles in adolescent girls with type 1 diabetes who have poor blood sugar control. Researchers will give some participants dulaglutide plus insulin, while others get only insulin. The goal is to see if the drug reduces irregular periods, such as missed or unpredictable cycles.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
Dulaglutide (a GLP-1 receptor agonist)
What this could lead to
If it works, this could point toward a new way to improve menstrual health in teens with type 1 diabetes.
What could go wrong
This is a small, early-phase study (50 participants) with no blinding. Results may not apply to all teens, and dulaglutide may cause side effects like nausea or gastrointestinal issues.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FEMALE REPRODUCTIVE HEALTH are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Ain shams university

    Cairo, Cairo Governorate, 00202, Egypt

  • Ain shams university

    Cairo, Cairo Governorate, 11517, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.